Hiroko Hosoi
Tokyo, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 12 publications
Expanding indications and developmental landscape of HER2-targeted therapies in breast cancer: a pharmacotherapeutic perspective.
Journal: Expert opinion on pharmacotherapy
Published: November 17, 2025
A phase II study of FOLFIRINOX with primary prophylactic pegfilgrastim for chemotherapy-naïve Japanese patients with metastatic pancreatic cancer.
Journal: International journal of clinical oncology
Published: February 24, 2021
Multicenter Phase II Trial of Axitinib Monotherapy for Gemcitabine-Based Chemotherapy Refractory Advanced Biliary Tract Cancer (AX-BC Study).
Journal: The oncologist
Published: July 11, 2020
Germline mutations in cancer-predisposition genes in patients with biliary tract cancer.
Journal: Oncotarget
Published: July 22, 2019
Lipid profiling of pre-treatment plasma reveals biomarker candidates associated with response rates and hand-foot skin reactions in sorafenib-treated patients.
Journal: Cancer chemotherapy and pharmacology
Published: April 11, 2018
Germline variants in pancreatic cancer patients with a personal or family history of cancer fulfilling the revised Bethesda guidelines.
Journal: Journal of gastroenterology
Published: March 02, 2018
Quality evaluation of investigator-initiated trials using post-approval cancer drugs in Japan.
Journal: Cancer science
Published: September 14, 2016
Familial pancreatic cancer: Concept, management and issues.
Journal: World journal of gastroenterology
Published: August 07, 2016
A retrospective analysis of factors associated with selection of end-of-life care and actual place of death for patients with cancer.
Journal: BMJ open
Published: May 06, 2014
Usefulness of procalcitonin for severity assessment in patients with acute cholangitis.
Journal: Clinical laboratory
Published: March 20, 2013
Showing 1-12 of 12
Last Updated: 09/26/2026